Literature DB >> 22277645

Clinical efficacy of left ventricular pacing vector programmability in cardiac resynchronization therapy defibrillator patients for management of phrenic nerve stimulation and/or elevated left ventricular pacing thresholds: insights from the Efface Phrenic Stim study.

Norbert Klein1, Maika Klein, Heinrich Weglage, Oliver Przibille, Sven Fischer, Hans-Joachim Trappe, Frank Birkenhauer, Dietrich Pfeiffer.   

Abstract

AIMS: Elevated left ventricular (LV) pacing thresholds or phrenic nerve stimulation (PNS) might be possible reasons for absence of continuous and effective biventricular stimulation. This study investigated the benefit and clinical efficacy of the ability to choose one out of three different LV pacing vectors for the management of suboptimal LV pacing thresholds and PNS. METHODS AND
RESULTS: This prospective, observational multicentre study enrolled 132 patients (Pts) implanted with a cardiac resynchronization therapy defibrillator, that offers three LV pacing vectors: (i) Bipolar; (ii) LVtip ↔ RVcoil; (iii) LVring ↔ RVcoil (RV = right ventricular). Left ventricular pacing thresholds and PNS thresholds were obtained in sitting and left lateral body position for all programmable LV pacing vectors at hospital discharge and follow up (FU). In 97%, a bipolar transvenous LV lead was successfully implanted. In 87% of Pts at least one acceptable pacing vector could be identified that provides good pacing threshold (≤ 2.5 V at 5 ms) and acceptable margin to PNS (≥ 2:1). This is an increase of 18% compared with conventional bipolar systems (74%) with two LV vectors and of 25% compared with unipolar systems (70%). The LVtip ↔ RVcoil vector provided the best LV pacing thresholds, but the highest rate of PNS.
CONCLUSIONS: The programmability of LV pacing vectors is a powerful feature to avoid PNS and obtain acceptable LV pacing thresholds. In order to retain reprogramming options for LV vectors during FU, LV pacing leads with at least two electrodes should be chosen whenever possible.

Entities:  

Mesh:

Year:  2012        PMID: 22277645     DOI: 10.1093/europace/eur412

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  4 in total

Review 1.  Phrenic nerve stimulation in cardiac resynchronization therapy.

Authors:  Ghassan Moubarak; Abdeslam Bouzeman; Jacky Ollitrault; Frederic Anselme; Serge Cazeau
Journal:  J Interv Card Electrophysiol       Date:  2014-06-17       Impact factor: 1.900

2.  Comparison of different pacing strategies to minimize phrenic nerve stimulation in cardiac resynchronization therapy.

Authors:  Jose F Huizar; Karoly Kaszala; Jayanthi N Koneru; Leroy R Thacker; Kenneth A Ellenbogen
Journal:  J Cardiovasc Electrophysiol       Date:  2013-04-26

3.  Phrenic nerve stimulation in CRT patients and benefits of electronic lead repositioning: the ERACE trial.

Authors:  Stephan Goetze; Pascal Defaye; Alexander Bauer; Matthias Merkel; Olivier Bizeau; Sven Treusch; Klaus Contzen; Claus Juenger; Joachim Winter
Journal:  J Interv Card Electrophysiol       Date:  2013-07-19       Impact factor: 1.900

4.  The Use of a Quadripolar Left Ventricular Lead Increases Successful Implantation Rates in Patients with Phrenic Nerve Stimulation and/or High Pacing Thresholds Undergoing Cardiac Resynchronisation Therapy with Conventional Bipolar Leads.

Authors:  Marc-Alexander Ohlow; Bernward Lauer; Michele Brunelli; Yunis Daralammouri; Christoph Geller
Journal:  Indian Pacing Electrophysiol J       Date:  2013-03-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.